伊维菌素
阿维链霉菌
阿维菌素
抗寄生虫药
抗寄生虫的
生物
药理学
线虫
医学
链霉菌
动物
细菌
病理
生态学
遗传学
解剖
作者
William C. Campbell,Michael H. Fisher,E. O. Stapley,Georg Albers-Schönberg,Theodore A. Jacob
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:1983-08-26
卷期号:221 (4613): 823-828
被引量:741
标识
DOI:10.1126/science.6308762
摘要
Ivermectin is the 22,23-dihydro derivative of avermectin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis. It is active at extremely low dosage against a wide variety of nematode and arthropod parasites, apparently by virtue of its action on the mediation of neurotransmission by gamma-aminobutyric acid. It is now in commercial use in various countries for the treatment and control of parasites in cattle, horses, and sheep, and is expected to become available for use in swine and dogs. Since studies with the drug in man are in a preliminary stage, it is not yet known whether ivermectin will be useful in human medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI